SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (2456)4/18/1997 10:34:00 PM
From: WWS   of 4342
 
Robin, Immudyne (IMMD) is already marketing two supplements to stimulate immune system functions: NSC-24 and Macroforce. Their stock isn't doing any better than PRLN's. A note to SSB and Rick--PRLN paid 1.6 million for Pacific Liaisons in 1994, part of which was their collection of 2,500 TCM extracts. But, without a single success story to tell, I doubt that PRLN would get much more than that today if it tried to sell this collection of unproven extracts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News